Global Rabies Treatment Market 2017-2021

狂犬病治療薬の世界市場

◆タイトル:Global Rabies Treatment Market 2017-2021
◆商品コード:IRTNTR13076
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年5月3日
◆ページ数:70
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、狂犬病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、狂犬病治療薬の世界市場規模及び予測、用途別分析、製品別分析、投与経路(ROA)別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Rabies TreatmentRabies is a condition that causes thousands of deaths worldwide every year. Humans contract rabies when bitten by an animal infected with the rabies virus. The virus is transmitted when the saliva of the infected animal touches an open wound or mucous membrane. It infects the brain and ultimately leads to death.

Technavio’s analysts forecast the global rabies treatment market to grow at a CAGR of 4.91% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global rabies treatment market for 2017-2021. To calculate the market size, the report considers the rabies vaccine sales for both human and animal usage.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Rabies Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Cadila Healthcare
• GlaxoSmithKline
• Merial
• Sanofi

[Other prominent vendors]
• Merck
• Pfizer

[Market driver]
• The need for contamination-free vaccines with novel culture media

• For a full, detailed list, view our report

[Market challenge]
• High maintenance costs of vaccines
• For a full, detailed list, view our report

[Market trend]
• Introduction of monoclonal antibodies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Understanding rabies
• Disease overview
• Progression of disease
• Zoonotic diseases in developing countries
• Future prediction and prevention of rabies
• Rabies management: Current scenario

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by application
• Pre-exposure vaccination
• Post-exposure prophylaxis

PART 09: Market segmentation by product type
• CCVs
• RIGs
• NTVs

PART 10: Market segmentation by route of administration
• Intradermal route of administration
• Intramuscular route of administration
• Oral route of administration

PART 11: Geographical segmentation
• Rabies treatment market in Americas
• Rabies treatment market in EMEA
• Rabies treatment market in APAC

PART 12: Decision framework

PART 13: Drivers and challenges
• Market drivers
• Market challenges

PART 14: Market trends
• Zero human rabies by 2030 initiative
• Introduction of monoclonal antibodies
• Growing vendor interest in vaccines with short immunization periods

PART 15: Vendor landscape
• Competitive scenario

PART 16: Key vendor analysis
• Cadila Healthcare
• GlaxoSmithKline
• Merial
• Sanofi
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Rabies: Stages of disease progression
Exhibit 02: Approaches to rabies management
Exhibit 03: Pipeline summary: Number of drug candidates by product type 2016
Exhibit 04: Pipeline landscape
Exhibit 05: Snapshot of pipeline trends in global rabies treatment market
Exhibit 06: Global rabies treatment market snapshot
Exhibit 07: Global rabies treatment market 2016-2021 ($ millions)
Exhibit 08: Opportunity analysis in global rabies treatment market
Exhibit 09: Five forces analysis
Exhibit 10: Global rabies treatment market by application
Exhibit 11: Global rabies treatment market by application: Consumption scenario in developing versus developed countries 2016
Exhibit 12: Market segmentation based on product type
Exhibit 13: Global rabies treatment market by product type 2016
Exhibit 14: Global CCV for rabies treatment market 2016-2021 ($ millions)
Exhibit 15: Global RIG for rabies treatment market 2016-2021 ($ millions)
Exhibit 16: Global NTV for rabies treatment market 2016-2021 ($ millions)
Exhibit 17: Market segmentation based on route of administration
Exhibit 18: Global rabies treatment market share by route of administration 2016
Exhibit 19: Global rabies treatment market by geography 2016 and 2021
Exhibit 20: Global rabies treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 21: Global rabies treatment market share by geography 2016-2021
Exhibit 22: Market scenario in Americas
Exhibit 23: Rabies treatment market in Americas 2016-2021 ($ millions)
Exhibit 24: Market scenario in EMEA
Exhibit 25: Rabies treatment market in EMEA 2016-2021 ($ millions)
Exhibit 26: Market scenario in APAC
Exhibit 27: Rabies treatment market in APAC ($ millions)
Exhibit 28: Competitive structure analysis of global rabies treatment market 2016
Exhibit 29: Cadila Healthcare: Key highlights
Exhibit 30: Cadila Healthcare: Strength assessment
Exhibit 31: Cadila Healthcare: Strategy assessment
Exhibit 32: Cadila Healthcare: Opportunity assessment
Exhibit 33: GlaxoSmithKline: Key highlights
Exhibit 34: GlaxoSmithKline: Strength assessment
Exhibit 35: GlaxoSmithKline: Strategy assessment
Exhibit 36: GlaxoSmithKline: Opportunity assessment
Exhibit 37: Merial: Key highlights
Exhibit 38: Merial: Strength assessment
Exhibit 39: Merial: Strategy assessment
Exhibit 40: Merial: Opportunity assessment
Exhibit 41: Sanofi: Key highlights
Exhibit 42: Sanofi: Strength assessment
Exhibit 43: Sanofi: Strategy assessment
Exhibit 44: Sanofi: Opportunity assessment



【掲載企業】

Cadila Healthcare, GlaxoSmithKline, Merial, Sanofi, Merck and Pfizer.


【資料のキーワード】

狂犬病、狂犬病治療薬、医薬品

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[狂犬病治療薬の世界市場] (Global Rabies Treatment Market 2017-2021 / IRTNTR13076)販売に関する免責事項
[狂犬病治療薬の世界市場] (Global Rabies Treatment Market 2017-2021 / IRTNTR13076)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆